Sources | Names Used |
---|---|
CTRPv2 | ML334 diastereomer |
PharmacoGx | ML334 diastereomer |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ERMAP | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
mRNA | DCTN4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
mRNA | PRRX1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
mRNA | CITED1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
mRNA | ABHD2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
mRNA | FMN1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
mRNA | HEMGN | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
mRNA | SPTA1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
mRNA | FSHB | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
mRNA | CA1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |